Who We Are

We are your guide to timely, fact-based insights and actionable solutions. We connect the dots between the research and your business objectives.

Who We Work With

Some of the most iconic brands in the world have trusted us since 1983 and we are proud to have clients that continue to work with us after 30 years of successful business together.

What We Do

We deliver on our promise. Our promise to provide the highest quality marketing research insights with a reliable team of industry experts that you can count on every step of the way.

How We Do It

We care about the quality of our deliverables. We care about the impact that our insights and solutions have on your organization. We care about our relationships with our clients and with each other.

Let’s Connect

We know that trust must be built between us over time. So, let’s get started.

Privacy Policy
Copyright © 2023 KS&R, Inc.
All Rights Reserved
Multi-Stakeholder Influence on Dispensing Outcomes Hero Image
Engaging Hard-to-Reach Specialty Pharmacists

Multi-Stakeholder Influence on Dispensing Outcomes


Specialty pharmaceutical products are the prevalent innovation driver for the pharmaceutical industry today, moving through considerably more fragmented and complex channels than traditional retail-based products. For brands to be successful, manufacturers need to acutely understand the different players and influences in this evolving landscape and the impact on the patient journey. With the introduction of generic specialty products and biosimilars, the brand journey may not be clear. Our research focused on three key players in the ecosystem – the HCP, Payer, and Specialty Pharmacy to learn how their interactions ultimately determined what treatment(s) patients receive.

A triangulation of research approaches – both qual and quant – were utilized with HCP/office staff and specialty pharmacists to understand the barriers and pain points in dispensing a specialty pharmaceutical product with a generic within the therapeutic class. It is critical to understand the specific pain points related to communications across stakeholders.

How HCPs and SPs handle barriers to dispensing vary – with the best interactions based on the quality and efficiency of their relationship. While Specialty Pharmacies have the ability to dispense AB rated generics instead of the brand (for non-DAW scripts), this is not always the practice. Furthermore, Specialty Pharmacies are often measured on performance metrics tied to patient outcomes. This insight enabled the client to focus on reinforcing brand differentiation, availability of patient copay saving programs, and other patient assistance programs to help stakeholders engage with patients.